Investing.com - AstraZeneca (NASDAQ:AZN) ADR reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
AstraZeneca ADR announced earnings per share of $1.67 on revenue of $10.98B. Analysts polled by Investing.com anticipated EPS of $0.77 on revenue of $10.78B.
AstraZeneca ADR shares are down 44.74% from the beginning of the year and are trading at $61.05 , down-from-52-week-high.
AstraZeneca ADR follows other major Healthcare sector earnings this month
AstraZeneca ADR's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar